Core Insights - The company reported a revenue of 1.46 billion yuan for the first half of 2025, representing a year-on-year increase of 28.2%, and a net profit of 170 million yuan, up 35.5% year-on-year [1] - The company's three main business segments showed strong growth, with the sub-health medical service revenue doubling [1] Revenue Breakdown - Beauty and health services generated 810 million yuan, a year-on-year increase of 29.6%, accounting for 55.2% of total revenue, driven by improved same-store sales and the acquisition of the smart beauty brand Nairui [1] - Medical beauty services achieved 500 million yuan in revenue, up 13.0% year-on-year, representing 34.2% of total revenue, supported by the execution of the "internal growth + external acquisition" strategy [1] - Sub-health medical services reached 150 million yuan, a significant increase of 107.8% year-on-year, making up 10.6% of total revenue, attributed to the strategy attracting members and refined operations [1] Profitability Metrics - The gross margin for the first half of 2025 was 49.3%, an increase of 2.3 percentage points year-on-year [2] - The net profit margin stood at 11.70%, reflecting a year-on-year increase of 0.62 percentage points [2] - The company maintained a stable expense ratio, with sales, management, and R&D expense ratios at 17.19%, 16.22%, and 1.44%, respectively [2] Strategic Initiatives - The company emphasized its "internal growth + external acquisition" strategy, with the acquisition of Nairui, the second-largest brand in China's beauty industry, expected to be completed by July 2024 [2] - Nairui contributed 277 million yuan in revenue during the first half of 2025, with an adjusted net profit margin increasing from 6.5% to 10.4% post-acquisition [2] - The company plans to enhance Nairui's core advantages and implement its first AI digital transformation project, the "Smart Beauty 2.0 System" [2] Membership Growth - The company reported a 47.8% year-on-year increase in customer traffic to 920,000 visits at direct stores, and active membership grew by 46.5% to 120,000 [3] - Approximately 20% of beauty and health service members upgraded to medical beauty or sub-health services, driving higher-value business penetration [3] Investment Outlook - The company is expected to achieve net profits of 330 million yuan, 380 million yuan, and 430 million yuan for 2025-2027, representing year-on-year growth of 43.9%, 17.0%, and 12.2% respectively [3] - The current stock price corresponds to a price-to-earnings ratio of 23X, 20X, and 18X for 2025-2027 [3]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [4]. Core Insights - The company achieved significant growth in the first half of 2025, with revenue reaching 1.46 billion RMB, a year-on-year increase of 28.2%, and net profit of 170 million RMB, up 35.5% [1]. - The "internal growth + external acquisition" strategy has proven effective, particularly with the acquisition of the brand Nairui, which contributed 277 million RMB in revenue and improved its net profit margin from 6.5% to 10.4% [3]. - The company reported a gross margin of 49.3%, an increase of 2.3 percentage points year-on-year, and a net profit margin of 11.70%, up 0.62 percentage points [3]. Revenue Breakdown - The revenue from beauty and wellness services was 810 million RMB, a 29.6% increase, accounting for 55.2% of total revenue. Direct store income was 740 million RMB, up 31.0% [2]. - Medical beauty services generated 500 million RMB, a 13.0% increase, representing 34.2% of total revenue [2]. - The revenue from sub-health medical services doubled to 150 million RMB, a 107.8% increase, making up 10.6% of total revenue [2]. Membership Growth - The company reported a 47.8% increase in direct store customer traffic, reaching 920,000 visits, and active membership grew by 46.5% to 120,000 [4]. - Approximately 20% of beauty and wellness service members upgraded to medical beauty or sub-health services, enhancing the penetration of high-value business [4]. Financial Forecast - The company is projected to achieve net profits of 330 million RMB, 380 million RMB, and 430 million RMB for 2025, 2026, and 2027, respectively, with growth rates of 43.9%, 17.0%, and 12.2% [4][5]. - The current stock price corresponds to a price-to-earnings ratio (P/E) of 23X for 2025, 20X for 2026, and 18X for 2027 [4][5].

星标 ★ IPO日报 精彩文章第一时间推送 4月17日，深圳光韵达光电科技股份有限公司（300227.SZ）（下称"光韵达"、"上市公司"）股价以8.23元收盘，上涨5.51%。 4月16日晚间，国内激光制造龙头光韵达发布公告，拟以现金不超过6.5亿元收购深圳市亿联无限科技股份有限公司（下称"亿联无限"、"标的公 司"）100%股份。 交易双方已签署《股份转让意向协议书》，最终收购比例将协商确定，预计不构成关联交易或重大资产重组。 此次收购标志着，光韵达从激光智能制造向网络通信设备制造领域的战略性延伸，旨在完成电子制造产业链的上下游整合，并拓展海外市场。 制图：李昕 同期，上市公司产品毛利率由2020年的42.45%一路下滑至2024年29.38%。 制图：李昕 制图：佘诗婕 增收不增利 据悉，光韵达是国内激光智能制造解决方案的龙头企业，业务涵盖SMT精密模板、3D打印、智能检测设备等领域，长期服务于华为、富士康等头部 客户。 公司近年来通过"内生+外延"战略持续扩张，不过从业绩层面来看，上市公司已经连续四年出现增收不增利的情况。 2020年至2024年，上市公司营业收入一路上涨， 由8.87亿元持续上涨至2 ...